TCL Archive DCPC Board Approves $40 Million In New Concepts, Including Three In Breast Cancer, One In Melanoma October 12, 1984
TCL Archive VeriStrat Biomarker Test Predicts Treatment Outcomes In Phase III NSCLC Trial May 30, 2014